ES2050114T3 - Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia. - Google Patents

Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.

Info

Publication number
ES2050114T3
ES2050114T3 ES87305505T ES87305505T ES2050114T3 ES 2050114 T3 ES2050114 T3 ES 2050114T3 ES 87305505 T ES87305505 T ES 87305505T ES 87305505 T ES87305505 T ES 87305505T ES 2050114 T3 ES2050114 T3 ES 2050114T3
Authority
ES
Spain
Prior art keywords
lav
htlv
iii
monoclonal antibodies
lymphophenopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87305505T
Other languages
English (en)
Inventor
Janela Mcclure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2050114T3 publication Critical patent/ES2050114T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBEN ANTICUERPOS MONOCLONALES HUMANOS CAPACES DE REACCIONAR ESPECIFICAMENTE CON UN ANTIGENO DETERMINADO DE LAV/HTLV-III Y LINEAS CELULARES PRODUCTORAS DE ESTOS ANTICUERPOS MONOCLONALES. LOS ANTICUERPOS MONOCLONALES HUMANOS PUEDEN SER UTILIZADOS EN UN METODO PARA DETERMINAR LA PRESENCIA DE LAV/HTLV-III EN MUESTRAS BIOLOGICAS O EN UN METODO PARA SEPARAR ANTIGENOS ESPECIFICOS DETERMINANTES DE LAV/HTLV-III DE UNA MEZCLA. COMPOSICIONES FARMACEUTICAS CONTENIENDO EL MENCIONADO ANTICUERPO MONOCLONAL HUMANO, Y UN METODO PARA REDUCIR SIGNIFICATIVAMENTE LA INEFECTIVIDAD DE LAV/HTLV-III EN ANIMALES USANDO LA COMPOSICION.
ES87305505T 1986-06-23 1987-06-22 Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia. Expired - Lifetime ES2050114T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87757986A 1986-06-23 1986-06-23

Publications (1)

Publication Number Publication Date
ES2050114T3 true ES2050114T3 (es) 1994-05-16

Family

ID=25370267

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87305505T Expired - Lifetime ES2050114T3 (es) 1986-06-23 1987-06-22 Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.

Country Status (12)

Country Link
EP (1) EP0251612B1 (es)
JP (1) JP2626680B2 (es)
KR (1) KR910001808B1 (es)
AT (1) ATE103002T1 (es)
AU (1) AU614714B2 (es)
CA (1) CA1339830C (es)
DE (1) DE3789333T2 (es)
DK (1) DK169582B1 (es)
ES (1) ES2050114T3 (es)
IE (1) IE63109B1 (es)
IL (1) IL82926A (es)
PT (1) PT85149B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
ATE135743T1 (de) * 1987-11-13 1996-04-15 Hermann Katinger Monoklonale menschliche antikörper gegen hiv-i
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US5298419A (en) * 1988-03-31 1994-03-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
CA2028121A1 (en) * 1989-02-28 1990-08-29 Susan Zolla-Pazner Human monoclonal antibodies to human immunodeficiency virus
US5731189A (en) * 1989-02-28 1998-03-24 New York University Human monoclonal antibodies to human immunodeficiency virus
WO1990010457A1 (en) * 1989-03-14 1990-09-20 New York University Method of treating hiv infections using immunotoxins
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE19809785C2 (de) * 1998-03-08 2000-02-10 Wolfgang Bergter Radioimmunpharmakon zur Behandlung der HIV-1-Infektion
US6680209B1 (en) 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
CN106434833A (zh) 2004-05-23 2017-02-22 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN108779168A (zh) 2015-12-05 2018-11-09 沃迪奥斯大学医院中心 Hiv结合剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
AU8127187A (en) * 1986-12-03 1988-06-09 Ici Australia Operations Proprietary Limited Mine roof supporting element

Also Published As

Publication number Publication date
PT85149B (pt) 1990-07-31
IE63109B1 (en) 1995-03-22
IE871587L (en) 1987-12-23
JP2626680B2 (ja) 1997-07-02
KR880000585A (ko) 1988-03-28
DK304087D0 (da) 1987-06-15
DE3789333T2 (de) 1994-07-07
IL82926A0 (en) 1987-12-20
DK304087A (da) 1987-12-24
AU7451287A (en) 1987-12-24
EP0251612A2 (en) 1988-01-07
AU614714B2 (en) 1991-09-12
ATE103002T1 (de) 1994-04-15
CA1339830C (en) 1998-04-21
EP0251612B1 (en) 1994-03-16
PT85149A (en) 1987-07-01
DK169582B1 (da) 1994-12-12
EP0251612A3 (en) 1990-05-23
DE3789333D1 (de) 1994-04-21
IL82926A (en) 1991-07-18
KR910001808B1 (ko) 1991-03-26
JPS63107998A (ja) 1988-05-12

Similar Documents

Publication Publication Date Title
ES2050114T3 (es) Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
SE8604007L (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
DE59010913D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
ATE96675T1 (de) Spezifische sekretions-exkretions-antigene von toxoplasma gondii, deren expressionsprodukte, verfahren zu deren herstellung und deren diagnostische und prophylaktische anwendungen.
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2056075T3 (es) Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso.
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
SE8305667L (sv) Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem
DK0489771T3 (da) Modificerede humane anti-Rh(D)-antistoffer
ATE59860T1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
UA8704A1 (uk) Спосіб визhачеhhя аhтигеhhої hовими вірусу грипу

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251612

Country of ref document: ES